CD20, Human (Obinutuzumab biosimilar) Antibody from KMD BIOSCIENCE CO. LTD.

Search, find, compare suppliers for anti-CD20, Human (Obinutuzumab biosimilar) antibody, protein, ELISA kits.

Edit 
Antigenic SpecificityCD20, Human (Obinutuzumab biosimilar)
CloneObinutuzumab
Host SpeciesRecombinant Mouse
Reactive Specieshuman
IsotypeIgG1 kappa
Formatpurified
Size1mg, 5mg
Concentration1mg/ml
ApplicationsIP, IF, FuncS, FCM, Neut, ELISA, ICC
Reviews / RatingsIf you have used this antibody, please help fellow researchers by submitting reviews to pAbmAbs and antYbuddY.
DescriptionAnti-Human CD20 Recombinant Antibody (Obinutuzumab). Obinutuzumab (called afutuzumab until 2009) is a humanized anti-CD20 monoclonal antibody, originated by GlycArt Biotechnology AG and developed by Roche as a cancer treatment.
Immunogenn/a
Other NamesAnti-CD20 Recombinant Antibody, Research Grade Obinutuzumab, Anti-Human CD20 Recombinant Antibody(Obinutuzumab), GA101, RG7159, RO5072759, Antibody Drug Analogues, Monoclonal Antibody, YR1155, Research Grade Biosimilars, Biosimilar Antibody
Gene, Accession #CAS: 949142-50-1
Catalog #YR1155
Priceplease inquire
Order / More InfoCD20, Human (Obinutuzumab biosimilar) Antibody from KMD BIOSCIENCE CO. LTD.
Product Specific Referencesn/a
KMD BIOSCIENCE CO. LTD.
KMD BIOSCIENCE CO. LTD.
KMD BIOSCIENCE CO. LTD.
FL-4, Building A5
International Enterprise Community
Tianjin CHINA
P: 400-621-6806

info@kmdbioscience.com
Sales: sales@kmdbiosci.com

https://www.kmdbioscience.com

Profile of KMD BIOSCIENCE CO. LTD.
Return to Antibodies

© 1980 - 2024 Linscott's Directory, Linscott's USA. All rights reserved.